Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Protocol1Independent statistical analysis of Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03560323).
- Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers: Complete Statistical AnalysisIndependent statistical analysis of Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Proton Pump Inhibitors and Dysbiosis in Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Proton Pump Inhibitors and Dysbiosis in Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01458990).
- Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00592592).
- Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340495).
- PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region: Complete Statistical AnalysisIndependent statistical analysis of PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PROVE-AAAIndependent statistical analysis of Preferences for Open Vs. Endovascular Repair for Abdominal Aortic Aneurysm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03115346).
- PROVE-HCCIndependent statistical analysis of Trial Comparing PLA to HIGRT (PROVE-HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03402607).
- ProVentIndependent statistical analysis of Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ProVIDEIndependent statistical analysis of ProVee Urethral Expander System IDE Study (ProVIDE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05186740).
- Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: Complete Statistical AnalysisIndependent statistical analysis of Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01849822).
- Provision of HIV Self-Test Kit to Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Provision of HIV Self-Test Kit to Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03021005).
- Proxalutamide Treatment for Hospitalized COVID-19 Patients: Complete Statistical AnalysisIndependent statistical analysis of Proxalutamide Treatment for Hospitalized COVID-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04728802).
- PRP vs Corticosteroid in Baker’s Cyst: Complete Statistical AnalysisIndependent statistical analysis of PRP vs Corticosteroid in Baker's Cyst: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02249377).
- PRP vs PRP Plus IGF for Patellar Tendinosis: Complete Statistical AnalysisIndependent statistical analysis of PRP vs PRP Plus IGF for Patellar Tendinosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04350827).
- PS PilotIndependent statistical analysis of The PortionSize Smartphone App Pilot (PS Pilot): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04494971).
- PS-010Independent statistical analysis of CryoCath Freezor CryoAblation Catheter System (CRYOFACTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621621).
- PSADIndependent statistical analysis of Personal Sound Amplification Smartphone Application Feasibility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03652909).
- Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01943994).
- Psilodep-RCTIndependent statistical analysis of Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03429075).
- PsiTODIndependent statistical analysis of Internet-delivered Psychotherapy for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02091856).
- PSMA PETIndependent statistical analysis of Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02611882).
- Psoriatic Arthritis Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Psoriatic Arthritis Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05623345).
- PSUNRISE – Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: Complete Statistical AnalysisIndependent statistical analysis of PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Psychological Support for Patients With an Implantable Cardioverter Defibrillator: Complete Statistical AnalysisIndependent statistical analysis of Psychological Support for Patients With an Implantable Cardioverter Defibrillator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00152763).
- PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00686842).
- PTCLIndependent statistical analysis of Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00865969).
- PTH Analog Type II Odontoid Fracture: Complete Statistical AnalysisIndependent statistical analysis of PTH Analog Type II Odontoid Fracture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04760782).
- PTI-125 for Mild-to-moderate Alzheimer’s Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of PTI-125 for Mild-to-moderate Alzheimer's Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03748706).
- PTNS-MIndependent statistical analysis of Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PTNS-MSIndependent statistical analysis of PTNS for Female Patients Suffering From Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05422625).
- PTOTtAVRIndependent statistical analysis of Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03117296).
- PTSCIndependent statistical analysis of Persistence-Targeted Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654107).
- PTSC-SIndependent statistical analysis of Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873337).
- PTSDIndependent statistical analysis of Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03574974).
- PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin’s Lymphoma That Have Not Responded to Standard Treatment: Complete Statistical AnalysisIndependent statistical analysis of PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pudendal Nerve Block for Hemorrhoidectomy: Complete Statistical AnalysisIndependent statistical analysis of Pudendal Nerve Block for Hemorrhoidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04251884).
- PUFFORIndependent statistical analysis of Pulmonary Function Using Non-invasive Forced Oscillometry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03346343).
- PULIndependent statistical analysis of Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pulse Pressure and Post-epidural Fetal Heart Rate Changes: Complete Statistical AnalysisIndependent statistical analysis of Pulse Pressure and Post-epidural Fetal Heart Rate Changes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02565485).
- Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars: Complete Statistical AnalysisIndependent statistical analysis of Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PUPs B-LONGIndependent statistical analysis of Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PuraBond PROOFIndependent statistical analysis of PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PureWick™ France and U.S. At-Home Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of PureWick™ France and U.S. At-Home Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05710718).
- PURSUITIndependent statistical analysis of A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PUSHIndependent statistical analysis of Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063880).
- Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection: Complete Statistical AnalysisIndependent statistical analysis of Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PVSIndependent statistical analysis of Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…